Spis treści:
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| Raport bieżący nr | 9 | / | 2022 | |||||||||
| Data sporządzenia: | 2022-08-02 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| Commencing sales of CompuFlo® Epidural System to the University of Scranton for incorporation in their Student Registered Nurse Anesthesia Curriculum | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that it has commenced sales of the CompuFlo Epidural system to the University of Scranton in Pennsylvania, USA for incorporation into the Student Registered Nurse Anesthesia (SRNA) program. The mission of the University of Scranton is to educate the students on the latest advancements in medicine to ensure the best patient and provider experience, so they can carry these skills forward into the workplace and throughout their careers. The Board of Directors of the Company believes this selection reinforces the proven clinical and safety benefits of the technology and that training the next generation of nurse anesthetists on the use of the instrument is critical in achieving our goal of establishing the CompuFlo Epidural system as the new standard of care in both labor and delivery, as well as pain management. |
||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
INFORMACJE O PODMIOCIE >>>
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2022-08-02 | Keisha Harcum | Controller | Keisha Harcum | ||
Źródło:Komunikaty spółek (ESPI)
